Delivery Order SPE2DB22D1017-SPE2DB25FG9CC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $20,726.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. Isotretinoin...
- The Defense Logistics Agency awarded a delivery order valued at $2,690.14 to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent oral retinoid medication primarily used for severe acne treatment, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units) with a ceiling value of $4,685.08. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by August 28, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract ceiling value of $1,645.60. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30 count) with a ceiling value of $1,835.95, effective August 19, 2025, with ultimate completion by August 20, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,016.27 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, with performance to take place at the contractor's Conshohocken, Pennsylvania facility. The contract was awarded without a set-aside designation through competitive procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) valued at $18,281.62 under a firm fixed-price contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a prescription medication primarily used for treating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract value of $2,590.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a contract ceiling value of $17,955.69. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded without a set-aside designation, indicating it was awarded through open competition. The contract is executed from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,093.00 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules (30-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9CCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Isotretinoin 30 mg capsules (30-count unit) with a ceiling value of $5,913.36. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and was competitively awarded without a set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent medication primarily used for severe acne treatment and dermatological conditions, representing one component of the broader pharmaceutical supply requirements within the federal medical procurement system. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs, enabling the company to supply an extensive range of brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's selection for this delivery order demonstrates its established capability as a critical vendor within the federal medical supply chain and reflects ongoing confidence in the company's ability to meet DLA requirements across diverse pharmaceutical product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/6/25 |